Implanet SA (IMPZY) Starts Presentation at 30th Annual ROTH Conference
Implanet (OTCQX: IMPZY) provides various spine, knee and arthroscopy orthopedic implants in France, the United States, and internationally. JAZZ™, the company’s flagship product, obtained 510(k) clearance from the FDA in the United States and the CE mark in Europe. The JAZZ™ Band latest generation implant is protected by four sets of global patents and is intended to improve the treatment of spinal disorders requiring spinal fusion surgery. The company’s R&D team focuses on a scientifically and clinically proven implant design, using top quality materials tested to the highest prevailing standards, associated with simple and user-friendly instrumentations. Implanet’s various workgroups, including…







